Medication

FILE - In this Oct. 1, 2020 file photo, an Amazon logo appears on an Amazon delivery van, in Boston. Amazon opened an online pharmacy Tuesday, Nov. 17 giving shoppers the chance to buy their medication and order refills on their phones and computers and have it delivered to their doorsteps in a couple of days. (AP Photo/Steven Senne, File)
November 17, 2020 - 6:04 pm
NEW YORK (AP) — Now at Amazon.com: insulin and inhalers. The retail colossus opened an online pharmacy Tuesday that allows customers to order medication or prescription refills, and have them delivered to their front door in a couple of days. The potential impact of Amazon's arrival in the...
Read More
Montana Advanced Caregivers owner Richard Abromeit talks about different strains of marijuana stored in a refrigerator at the Billings, Mont., medical marijuana dispensary on Nov. 11, 2020. Recreational marijuana initiatives passed in four states this year, from liberal New Jersey to conservative Montana and South Dakota. The results prove how broadly accepted marijuana has become throughout the country and across party lines. (AP Photo/Matthew Brown)
November 16, 2020 - 9:20 am
HELENA, Mont. (AP) — Bill Stocker could be considered the archetype of a conservative voter: He's a retired Marine and former police officer who voted for President Donald Trump. But he's also among the majority of South Dakota voters who broadly legalized marijuana this month. Stocker, 61, said...
Read More
FILE - In this July 10, 2018, file photo bottles of medicine ride on a belt at a mail-in pharmacy warehouse in Florence, N.J. President-elect Joe Biden is unlikely to get sweeping health care changes through a closely divided Congress, but there’s a menu of narrower actions he can choose from to make a tangible difference in affordability and coverage for millions of people. (AP Photo/Julio Cortez, File)
November 13, 2020 - 5:54 am
WASHINGTON (AP) — President-elect Joe Biden is unlikely to get sweeping health care changes through a closely divided Congress, but there’s a menu of narrower actions he can choose from to make a tangible difference on affordability and coverage for millions of people. With the balance of power in...
Read More
AP Illustration/Peter Hamlin
November 10, 2020 - 1:08 am
Do masks with antiviral coating offer more protection? It’s an intriguing idea, but there haven’t been enough rigorous independent studies to establish whether antiviral masks are better at protecting wearers or preventing the spread of the virus. Their specifics vary, but many antiviral masks are...
Read More
November 09, 2020 - 10:49 am
Researchers are stopping a study early after finding that a shot of an experimental medicine every two months worked better than daily pills to help keep women from catching HIV from an infected sex partner. The news is a boon for AIDS prevention efforts especially in Africa, where the study took...
Read More
In this Dec. 12, 2019 photo provided by Biogen, a scientist works on Alzheimer’s disease research in a laboratory at the drugmaker’s headquarters in Cambridge, Mass. On Friday, Nov. 6, 2020, a panel of outside experts will meet to advise the Food and Drug Administration on the drug, called aducanumab from Biogen Inc. and Japan’s Eisai Co. The drug does not cure or reverse Alzheimer’s; the claim is that it modestly slows the rate of decline. (David A. White/Biogen via AP)
November 06, 2020 - 5:50 pm
WASHINGTON (AP) — Government health advisers sharply criticized a closely watched Alzheimer’s drug on Friday, concluding there wasn’t enough evidence that the experimental drug slowed the brain-destroying disease. The panel of outside experts for the Food and Drug Administration agreed that a...
Read More
FILE- This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth, N.J. Surging sales of cancer medicines and reduced spending helped Merck overcome a big hit from the coronavirus pandemic and increase its profit 12% in the second quarter. The drugmaker on Friday, July 31, 2020, increased its financial forecast for the year, all while it’s investing in development of two experimental vaccines and a possible treatment for COVID-19. (AP Photo/Seth Wenig, File)
October 27, 2020 - 3:08 pm
Drugmaker Merck, bouncing back from a $1.6 billion hit from the coronavirus pandemic in the second quarter, boosted its third-quarter profit by 55% and blew past Wall Street expectations. The strong result was due to sales slightly higher than a year ago, plus restrained spending. The Kenilworth,...
Read More
FILE - This is an April 26, 2017, file photo showing Eli Lilly corporate headquarters in Indianapolis. Eli Lilly continues to back a potential COVID-19 treatment despite research showing that it may not work on hospitalized patients. The drugmaker said Tuesday, Oct. 27, 2020, that It remains confident that its drug may stop COVID from developing in other patients. (AP Photo/Darron Cummings, File)
October 27, 2020 - 8:43 am
INDIANAPOLIS (AP) — Eli Lilly continues to back a potential COVID-19 treatment despite research showing that it may not work on hospitalized patients. The drugmaker said Tuesday it remains confident that its drug may stop COVID from developing in other patients. Researchers are still studying the...
Read More
FILE - In this March 2020 photo provided by Gilead Sciences, rubber stoppers are placed onto filled vials of the investigational drug remdesivir at a Gilead manufacturing site in the United States. Given through an IV, the medication is designed to interfere with an enzyme that reproduces viral genetic material. (Gilead Sciences via AP)
October 22, 2020 - 4:52 pm
The U.S. Food and Drug Administration has approved the first drug to treat COVID-19: remdesivir, an antiviral medicine given through an IV for patients needing hospitalization. The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15...
Read More
A bottle containing the drug Remdesivir is held by a health worker at the Institute of Infectology of Kenezy Gyula Teaching Hospital of the University of Debrecen in Debrecen, Hungary, Thursday Oct. 15, 2020. A large study led by the World Health Organization released on Friday, Oct. 16, 2020, suggests that the antiviral drug did not help hospitalized COVID-19 patients, in contrast to an earlier study that made the medicine a standard of care in the United States and many other countries. The results do not negate the previous ones, and the WHO study was not as rigorous as the earlier one led by the U.S. National Institutes of Health. But they add to concerns about how much value the pricey drug gives because none of the studies have found it can improve survival. (Zsolt Czegledi/MTI via AP)
October 16, 2020 - 11:46 am
GENEVA (AP) — A large study led by the World Health Organization suggests that the antiviral drug remdesivir did not help hospitalized COVID-19 patients, in contrast to an earlier study that made the medicine a standard of care in the United States and many other countries. The results announced...
Read More

Pages